Steven Kauder Email

Senior Director, Immunooncology . Everest Medicines

Current Roles

Employees:
161
Revenue:
$40.5M
About
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in mainland China and other Asian territories. We strive to be the partner of choice for innovative companies around the world with products that address critical unmet medical needs for patients in Greater China and have a high probability of market approval. The Everest Medicines team has deep expertise and extensive track record of high quality clinical development, regulatory affairs, CMC, business development and operations both in China and with leading global pharmaceutical companies. The company's Series A round was led by C-Bridge Capital, a top-tier China healthcare private equity firm, with US $800 million under management.
Everest Medicines Address
450 Lexington Ave
New York, NY
United States
Everest Medicines Email

Past Companies

Everest MedicinesSenior Director, Immunooncology
Coherus BioSciencesDirector, Biology - Translation and Development Sciences
SynthekineAssociate Director, In Vitro Pharmacology

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.